Chinese Biotech Innovators Push Overseas as Sector Faces Reckoning
After years of falling valuations and stalled IPO activity, China’s innovative drug industry is showing early signs of a comeback. A spate of...
287 Views
CX Daily: Chinese Biotech Is Having a ‘DeepSeek Moment’
Drugs / Cover Story: Chinese biotech is having a ‘deepseek moment’ Hong Kong /: Hong Kong bets on stablecoins and AI to future-proof its financial...
377 Views
Asia Real Estate Tracker (18-Feb-2025): ADIA, Hines sell Shanghai Trophy Tower for $1.5B
ADIA and Hines sell Shanghai Tower for $1.5B, Keppel DC REIT sells German data centre, TPG offers $65M for Econ Healthcare, while Singapore home...
365 Views
CX Daily: Where Do Fake Covid Drugs Come From?
In Depth: Where do fake Covid drugs come from? Local Chinese governments paid $148 billion in interest in 2022. IMF raises China’s 2023 growth...
343 Views
CX Daily: Behind the Massive Sell-Off in Chinese Wealth Management Products
In Depth: Behind the massive sell-off in Chinese wealth management products. Pfizer CEO dismisses reports of a Paxlovid generic for China.
444 Views